Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Boston Scientific/Aspect Medical

This article was originally published in The Gray Sheet

  • News

Executive Summary

Boston Scientific makes $10 mil. equity investment in Aspect and is providing an additional $5 mil. credit facility to support development of Aspect's Bispectral Index (BIS) anesthetic effect/brain monitoring technology for use in gastrointestinal endoscopy, interventional cardiology and radiology suites. The BIS is currently available in intensive care units and operating rooms (11"The Gray Sheet" Feb. 4, 2002, p. 18). In return, Aspect has granted Boston Scientific an option for worldwide distribution rights for the specialty procedures market, as well as an option to purchase up to an aggregate of 25% of Aspect's voting securities in the open market...

Table

View full table

Tags:
Latest Headlines

UK MHRA’s Strategic Approach To AI Will Be ‘Proportionate’ And Fit Well Internationally

Attorney: Proposed Data Privacy Law Would Ultimately Reduce Regulatory Burden

Senseonics Wins Marketing Authorization For Novel Insulin Delivery System

Liquid Biopsy Company Karius Raised $100M To Expand Its Test For Detecting Over 1,000 Pathogens

See All
UsernamePublicRestriction

Register

MT016983

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By